US Stock MarketDetailed Quotes

PAVM PAVmed

Watchlist
  • 0.7697
  • +0.0017+0.22%
Trading Mar 28 14:56 ET
12.67MMarket Cap1.54P/E (TTM)

PAVmed Key Stats

PAVmed Q4 2024 Earnings Date

Currency:USDMar 25, 2025

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
580.00K
10.00K
-570.00K
Miss Est.
-44.71%
-99.05%
-98.28%
EPS
-0.11
0.11
+0.22
Beat Est.
+94.03%
+105.74%
+200.91%
Buy

Mar 28, 2025

PAVmed Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 20.000K--
--2025/Q1-- / 20.000K--
Mar 25, 20252024/Q41.197M / 580.000K--
Nov 14, 20242024/Q3996.000K / 1.093M--
Aug 13, 20242024/Q2976.000K / 1.238M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 20.000K--
--2025/Q1-- / 20.000K--
Mar 25, 20252024/Q41.197M / 580.000K--
Nov 14, 20242024/Q3996.000K / 1.093M--
Aug 13, 20242024/Q2976.000K / 1.238M--

Unlock Free Earnings Estimates

PAVmed Earnings Reports

Read more

Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Mar 28, 2025

Buy

  • Buy

    50.00%
  • Hold

    50.00%
  • Sell

    0.00%

Price Target

No Data